JPH09165336A5 - - Google Patents

Info

Publication number
JPH09165336A5
JPH09165336A5 JP1996281918A JP28191896A JPH09165336A5 JP H09165336 A5 JPH09165336 A5 JP H09165336A5 JP 1996281918 A JP1996281918 A JP 1996281918A JP 28191896 A JP28191896 A JP 28191896A JP H09165336 A5 JPH09165336 A5 JP H09165336A5
Authority
JP
Japan
Prior art keywords
formula
compound
cancer
cyclopropyl
cyano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1996281918A
Other languages
English (en)
Japanese (ja)
Other versions
JP3996658B2 (ja
JPH09165336A (ja
Filing date
Publication date
Priority claimed from DE19539638A external-priority patent/DE19539638A1/de
Application filed filed Critical
Publication of JPH09165336A publication Critical patent/JPH09165336A/ja
Publication of JPH09165336A5 publication Critical patent/JPH09165336A5/ja
Application granted granted Critical
Publication of JP3996658B2 publication Critical patent/JP3996658B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP28191896A 1995-10-25 1996-10-24 癌疾患治療におけるイソオキサゾールおよびクロトンアミド誘導体の使用 Expired - Fee Related JP3996658B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19539638A DE19539638A1 (de) 1995-10-25 1995-10-25 Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen
DE19539638:3 1995-10-25

Publications (3)

Publication Number Publication Date
JPH09165336A JPH09165336A (ja) 1997-06-24
JPH09165336A5 true JPH09165336A5 (https=) 2004-10-21
JP3996658B2 JP3996658B2 (ja) 2007-10-24

Family

ID=7775689

Family Applications (1)

Application Number Title Priority Date Filing Date
JP28191896A Expired - Fee Related JP3996658B2 (ja) 1995-10-25 1996-10-24 癌疾患治療におけるイソオキサゾールおよびクロトンアミド誘導体の使用

Country Status (10)

Country Link
US (2) US5886033A (https=)
EP (1) EP0769296B1 (https=)
JP (1) JP3996658B2 (https=)
AT (1) ATE202704T1 (https=)
CA (1) CA2188228C (https=)
DE (2) DE19539638A1 (https=)
DK (1) DK0769296T3 (https=)
ES (1) ES2160197T3 (https=)
GR (1) GR3036754T3 (https=)
PT (1) PT769296E (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
EP1012150A4 (en) * 1997-05-19 2002-05-29 Sugen Inc HETEROARYLCARBOXAMIDE COMPOUNDS THAT ARE EFFECTIVE OF DISEASES CAUSED BY PROTEIN-TYROSIN-KINASE
EP0903345B1 (de) * 1997-08-08 2000-10-04 Aventis Pharma Deutschland GmbH Kristallform von 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)-anilid
EP0933633A1 (en) * 1997-12-11 1999-08-04 Hoechst Marion Roussel Deutschland GmbH Process for obtaining L-dihydroorotic acid and use thereof
DE19857009A1 (de) * 1998-12-10 2000-06-15 Aventis Pharma Gmbh Zubereitung mit verbesserter therapeutischer Breite, enthaltend Nukleotidsyntheseinhibitoren
US7365094B2 (en) 2002-12-23 2008-04-29 4Sc Ag Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
US7247736B2 (en) * 2002-12-23 2007-07-24 4Sc Ag Method of identifying inhibitors of DHODH
WO2004056746A1 (en) 2002-12-23 2004-07-08 4Sc Ag Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
MXPA06014754A (es) 2004-06-17 2007-06-22 Infinity Pharmaceuticals Inc Compuestos y metodos para inhibir la interaccion de las proteinas bcl con los componentes de enlace.
US7842815B2 (en) 2004-06-17 2010-11-30 Infinity Pharmaceuticals, Inc. Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
DE102006014165A1 (de) * 2006-03-24 2007-09-27 Schebo Biotech Ag Neue Isooxazol-Derivate und deren Verwendungen
TWI389895B (zh) 2006-08-21 2013-03-21 Infinity Discovery Inc 抑制bcl蛋白質與結合夥伴間之交互作用的化合物及方法
US11096934B2 (en) * 2015-09-01 2021-08-24 The Broad Institute, Inc. Compounds and methods useful for treating or preventing hematological cancers
CN111423374B (zh) * 2020-05-18 2023-03-21 合肥工业大学 一种二氢吡唑磺酰胺类化合物及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2854439A1 (de) * 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
ES2102367T3 (es) * 1990-05-18 1997-08-01 Hoechst Ag Amidas de acidos isoxazol-4-carboxilicos y amidas de acidos hidroxialquiliden-cianoaceticos, medicamentos que contienen estos compuestos y su utilizacion.
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-cycloalkyl-propanamides their tautomer forms and their salts preparation process and compositions containing them
NZ244814A (en) * 1991-10-23 1994-06-27 Hoechst Ag N-phenyl-2-cyano-3-hydroxycrotonamide derivatives and pharmaceutical compositions
GB9200275D0 (en) * 1992-01-08 1992-02-26 Roussel Lab Ltd Chemical compounds
GB9320299D0 (en) * 1993-10-01 1993-11-17 Roussel Lab Ltd Isoxazole derivatives
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
US5519042A (en) * 1994-01-13 1996-05-21 Hoechst Aktiengesellschaft Method of treating hyperproliferative vascular disease

Similar Documents

Publication Publication Date Title
JPH09165336A5 (https=)
JP2003520195A5 (https=)
JP2022124458A5 (https=)
CY1125544T1 (el) Ενωσεις 1,2,4-οξαδιαζολοβενζοϊκου οξεος και η χρηση τους για μη νοηματικη καταστολη και στη θεραπευτικη αγωγη ασθενειας
JPH09188658A5 (https=)
JP2005508962A5 (https=)
JP2005521713A5 (https=)
JP2005535586A5 (https=)
JP2010530372A5 (https=)
JP2022071077A5 (https=)
JP2001247459A5 (https=)
JP2006526590A5 (https=)
JP2005505588A5 (https=)
JP2012513390A5 (https=)
JP2023510746A5 (https=)
JP2004529114A5 (https=)
JP2007502295A5 (https=)
JP2002518502A5 (https=)
JP2005508337A5 (https=)
RU2004111601A (ru) Пиперидиновые производные и их применение в качестве модуляторов активности р ецепторов хемокина (в частности ccr5)
RU2005121908A (ru) Производные зн-хиназолин-4-она
DE602004014484D1 (de) Verwendung von azetidincarboxamidderivaten in therapie
JP2009503110A5 (https=)
JP2004525178A5 (https=)
JP2001515881A5 (https=)